• Prediction of response to Gefitinib in NSCLC by EGFR protein expression is increased by a novel antibody and the use of AQUA technology.
Auteur:Reyna Asuncion, B.; Yoshida, K.; Ranger-Moore, J.; Zhao, Jamie; Wynes, Murry W; Mascaux, Céline; Powell, William; Ikeda, N.; Hirsch, Fred R; Kato, Yasufumi
Informations sur la publication:Chicago Multidisciplinary Symposium in Thoracic Oncology (December 2010: Chicago, USA)
Statut de publication:Non publié, 2010
Sujet CREF:Sciences bio-médicales et agricoles
Note générale:S504, abstract 10